Home » Topics » BioWorld Science

BioWorld Science
RSS

Synthesis method enables functional studies identifying antibiotic's promise

Sep. 13, 2018

DSMB recommends continuation of EPITOPE study of Viaskin Peanut in toddlers

Sep. 12, 2018

Vital Therapies ceases development of ELAD cell-based therapy

Sep. 12, 2018

European Commission approves Veyvondi for adults with von Willebrand disease

Sep. 12, 2018

FINCH 2 study of filgotinib in rheumatoid arthritis meets primary endpoint

Sep. 12, 2018

Innate Pharma initiates phase I study of IPH-5401 with durvalumab in solid tumors

Sep. 12, 2018

Janssen Pharmaceutica presents OGA inhibitors

Sep. 12, 2018

Dual sHE inhibitor/PPAR-gamma agonist shows benefits to treat metabolic syndrome and diabetes in rat

Sep. 12, 2018

Prelude Therapeutics identifies new PRMT5 inhibitors

Sep. 12, 2018

Innate Tumor Immunity synthesizes new NLRP3 agonists for cancer

Sep. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...